June 20, 2002 Board Meeting minutes

The following Board Members and staff were present: Vice President (presiding officer) Paul Draugalis, Linda K. McCoy, Gerald Ritt, Dennis McAllister, Eugene Drake and Daniel Ketcherside.

Also present were: compliance officers Cheryl Frush, Mitzi Wilson, Dean Wright, Dennis Waggoner and Ed Hunter, Deputy Director Hal Wand, Assistant Attorney General Victoria Martin and Executive Director L. A. Lloyd.

Acting President Paul Draugalis convened the meeting at 9:00 a.m., welcomed a large audience to the meeting and requested Hal Wand to explain the process of obtaining Pharmacy Law C.E. for attending.

Mr. Draugalis acknowledged the presence of many pharmacy interns and thanked them for attending.

Mr. Lloyd introduced the Board's newest Compliance Officer Mitzi Wilson and made presentations to both the University of Arizona and Midwestern Universities' Colleges of Pharmacy of $1,000 scholarship funds courtesy of District 8, National Association of Boards of Pharmacy and the American Association of Colleges of Pharmacy organization.

Mr. Lloyd also presented framed certificates to Linda McCoy in recognition of completion of her board member training course and to Mr. Drake in recognition of Senate confirmation of his reappointment.

AGENDA ITEM I - APPROVAL OF MINUTES

On motion by Mr. McAllister and Mr. Ketcherside, the Board unanimously approved the minutes of the May 1 & 2, 2002 meeting.

On motion by Ms. McCoy and Mr. Ketcherside, the Board unanimously approved the minutes of the Executive Session from May 2, 2002 as presented.

AGENDA ITEM II - PERMITS & LICENSES

Pharmacy Permits

Deputy Director Hal Wand reported that all pharmacy permit applications, including one in the addendum, were in order and all fees have been paid. Following brief discussions with various applicants relating to scope of intended business practices, the following permits were approved

on motion by Mr. McAllister and Mr. Ketcherside, the Board unanimously approved all resident and domestic non-resident pharmacy applications:

• 3D Pharmacy
  1505 E. Weber Dr. Ste. 103A, Tempe, AZ 85281
  David Przybyszewski
• Arizona Senior Care Pharmacy
  55 W Hoover Avenue, #10, Mesa, AZ 85210
  Arizona Senior Care Pharmacy, Inc.
• Bashas' United Drug #034
  18785 S. 1-19 Frontage Rd., Green Valley, AZ 85614
  Bashas' Inc.
• Bashas' United Drug #067
  1000 N. Humphreys #112, Flagstaff, AZ 86002
  Bashas' Inc.
• Fry's Pharmacy #73
  6625 W. Happy Valley Rd., Phoenix, AZ 85310
  Smith Food & Drug Centers
• Fry's Pharmacy #74
  8375 W. Deer Valley Rd., Peoria, AZ 85382
  Smith Food & Drug Centers
• Low Cost Pharmacy
  5891 S McClintock Dr. #107, Tempe, AZ 85283
  (O) John Rao
• National Patient Services Pharmacy
  2117 48^th St., Suite 105, Tempe, AZ 85282
  National Patient Services Pharmacy Inc.
• Rx Formulations
  6047 E. University, Mesa, AZ 85205
  (O) Troy Albright
• Safeway Pharmacy #1139A
  1310 San Antonio Ave., Douglas, AZ 85607
  (O) Safeway Inc.
• Uptown Pharmacy
  5007 N Central Ave., Phoenix, AZ 85012
  (O) Oediv Corporation
• Walgreens Drug #6806
  17088 W Bell Rd., Surprise, AZ 85374
  Walgreens Arizona Drug Co.
• Walgreens Drug #07041
  9184 E. Valencia Rd., Tucson, AZ 85747
  Walgreen Arizona Drug Co.

NON-RESIDENT PERMITS (out of state)

• AdvancePriority Specialty Rx,LLC
  250 Technology Park #124A, Lake Mary, FL 32746
  AdvancePriority Specialty Rx,LLC
• American Diversified Pharmacies,Inc
  3920 Lennane Dr. Ste 100, Sacramento, CA 95834
  American Diversified Pharmacies,Inc.
• Ancona Drug Solutions
  1450 N. US Hwy 1 Ste 400, Ormond Beach, FL 32174
  Vincent J. Ancona
• California Pharmacy & Compounding Ctr.
  307 Placentia Ave., New Port Beach, CA 92663
  California Pharmacy & Compounding Ctr.
• Central Fill Inc.
  4415 Lewis Road, Harrisburg, PA 17111
  Central Fill, Inc.
• CFI of New Jersey, Inc.
  721 Ridgedale Ave., East Hanover, NJ 07936
  CFI of New Jersey, Inc.
• CVS/Pharmacy #6570
  2800 Enterprise St. Ste 5, Indianapolis, IN 46219
  Hook-SupeRx
• CVS ProCare Pharmacy #2921
  600 Penn Center Blvd., Pittsburgh, PA 15235
  ProCare Pharmacy Direct, Inc.
• Express Scripts - MO
  1400 Riverport Dr., Maryland Heights, MO 63043
  ESI Mail Pharmacy Services, Inc.
• Express Scripts - NM
  4500 Alexander Blvd. NE, Albuquerque, NM 87107
  ESI Mail Pharmacy Services, Inc.
• Express Scripts - NY
  433 River St. Ste 800, Troy, NY 12180
  ESI Mail Pharmacy Services, Inc.
• Express Scripts - PA
  3684 Marshall Lane, Bensalem, PA 19020
  ESI Mail Pharmacy Services, Inc.
• Freedom Drug
  12 Kent Way #120 B, Byfield, MA 01922
  Lynnfield Drug, Inc.
• Fresenius Medical Care North America
  300 Forsyth Hall Dr. Charlotte, NC 28273
  Fresenius Medical Care North America
• Healthcare Pharmacy
  140 Quigley Blvd., New Castle, DE 19720
  Chesapeake Infusion, Inc.
• InfuRX.
  3205 Kirby Whitten Pkwy #104B, Bartlett, TN 38134
  Chesapeake Infusion, Inc.
• International Pharmacy Solutions
  168 SE 1^st St. #602, Miami, FL 33131
  International Pharmacy Solutions
• Lynnfield Compounding
  12 Kent Way #120 C, Byfield, MA 01922
  Priority Healthcare Corporation
• Merck-Medco Rx Services-Tampa
  8880 Hidden River Pkwy, Tampa, FL 33637
  Merck-Medco Rx Services-Tampa
• MSC- Medical Services Company
  11764-1 Marco Beach Dr., Jacksonville, FL 32224
  MSC- Medical Services Company
• Pharmacare Direct #4991
  6820 Fairfield Business Dr., Fairfield, OH 45014
  PharmaCare Direct, Inc.
• Pharmacare Resources, Inc.
  500 Executive Blvd., Elmsford, NY 10523
  Accredo Health, Inc.
• Priority Healthcare Pharmacy
  250 Technology Park #124, Lake Mary, FL 32746
  Priority Healthcare Pharmacy
• Reliant Pharmacy Service
  4825 140^th Ave. Ste. A & B, Clearwater, FL 33762
  Lincare Services, Inc.
• Safeway Mail Service Pharmacy
  615 S. Ware Blvd. Ste. South, Tampa, FL 33619
  Safeway, Inc.
• Syncor International Corp.
  793 Via Lata, Colton, CA. 92324
  Syncor International Corp.
• Syncor International Corp.
  5000 Calle San Rafael #C-2, Palm Springs, CA. 92264
  Syncor International Corp.
• Y & S Pharmacy Services
  122 N. York Rd., Ste 3, Hatboro, PA 19040
  Contract Pharmacy Services

Wholesale Drug Permits

On motion by Ms. McCoy and Mr. Ketcherside, with Mr. Ritt abstaining, the Board unanimously approved the Wholesale Drug Permit applications:

FULL SERVICE

• Health Logic Immunization
  2990 E. Washington St., Phoenix, AZ 85034
  James Zorn

NON-PRESCRIPTION

• Target Store T-588
  7101 W. Van Buren St., Phoenix, AZ 85043
  Target Corporation
• Unit Dose, LTD.
  13832 n 32^nd St. Ste D-1, Phoenix, AZ 85032
  Unit Dose, LTD.

Parties present relevant to the consideration /approval of permits include: John Rao, Todd
LaChapelle, David Przybyszewski, Gary Gilbert, Roger Morris, Rich Randall, Dan Mason, Nate
Kaplan, Jennifer Dana, and Tom Bethune.

Pharmacist Licenses and Pharmacy Intern Licenses:

On motion by Mr. McAllister and Mr. Ritt, following a review of the applications, and on assurance from the staff that all were in order, the Board unanimously approved pharmacist licenses numbers S13148 thru S13192 and pharmacy intern licenses numbers I05607 thru I05644.

On motion by Mr.Ritt and Mr. Drake, the Board unanimously agreed to recess the open meeting and reconvene in executive session for the purpose of obtaining legal advice from Assistant Attorney General Victoria Martin.

On motion by Mr. Ketcherside and Mr. Drake, the Board unanimously agreed to reconvene in open session.

Presiding Officer, Paul Draugalis announced that consideration and decision relating to three pharmacy permit applications received from non-U.S. pharmacies is being tabled pending receipt of additional data and documents.

AGENDA ITEM III - SPECIAL REQUESTS

1. Maricopa County, this item is rescheduled to the August meeting at the request of the permitee.

2. Wal-Mart Stores, Bruce Painter, John Foss and Melissa Christensen appeared to demonstrate a technological advance designed to positively identify: through bar-code reading, the precise product selected for dispensing a prescription and a comparison of the item ordered and the item selected as well as providing an identification of the dispensing pharmacist. With the Board's approval, this technology may preclude the necessity of the pharmacist initialing the prescription upon electronic verification of it's accuracy.
Following the demonstration and explanation, Board Members and staff directed questions to the presenters. Upon conclusion of the discussion, Mr. Painter formally requested that the Board exempt Wal-Mart pharmacies, when using the technology, from two requirements in existing verification rules. The first exemption is from A.A.C. R4-23-403(D)(7) which requires pharmacists to verify the original stock bottle used by the technician to fill the prescription. The technology demonstrated eliminates the need for this step. The second exemption is from the requirement for the pharmacist to manually initial the finished prescription label as required in A.A.C. R4-23-403(D)(5).

On motion by Mr. McAllister and Mr. Drake, the Board recognized that the demonstrated technology (Scanning for Accuracy) meets the Board's purpose of verification.

And on motion by Mr. Ritt and Mr. Drake, pursuant to A.R.S. 32.1904(B)(6), the Board unanimously agreed to waive the requirement for a pharmacist to initial the label of prescriptions that are verified using the 'Scan For Accuracy System'.

3. John Bacovcin, R. Ph., this item is rescheduled to the August meeting at the request of the pharmacist.

4. George Wiesner and attorney Roger Morris, appeared requesting permission for Mr. Wiesner to reciprocate his recently reinstated New Jersey (NJ) pharmacist license to Arizona. Vice President Paul Draugalis invited Mr. Wiesner to provide a full summary of events leading to this request.
Board Member Linda McCoy, declared a conflict of interest and did not participate in this matter.
Mr. Wiesner and Mr. Morris collaborated to recap a series of issues, including a previously unreported suspension of Mr. Wiesner's NJ pharmacist license upon initially applying for licensure in Arizona in June 1997. A contrived scenario of false statements by Mr. Wiesner led to him being licensed as an intern in Arizona to acquire the experiential training required for full licensure. Mr. Wiesner admitted to the Board that he failed to reveal to the Board that his NJ license had been suspended, thus he filed an application in violation of the statute A.R.S. 32-1927(A)(13).
Mr. Draugalis stated that violation of A.R.S. 32-1927(A)(13) is grounds for revocation, suspension or denial of a license.
Roger Morris, speaking on behalf of Mr. Wiesner asked the Board to consider the letters of support and endorsement provided on Mr. Wiesner's behalf and to possibly extend an opportunity to him for licensure and for restoring his dignity and professional standing. Mr. Wiesner admitted that he had made a bad decision based on bad advice upon moving to Arizona in 1997 and that he regrets that decision and is seeking an opportunity to in essence, start over.
At the conclusion of Mr. Wiesner's comments, Board Members directed questions to him relevant to the events leading to the suspension of his NJ license and its subsequent reinstatement. On conclusion of the discussion and

on motion by Mr. Ketcherside and Mr. McAllister, the Board voted unanimously to deny Mr. Wiesner's request to pursue licensure by reciprocity based on the Board's finding of a violation of A.R.S. 32-1927(A)(13) in the previous application filed by Mr. Wiesner.

Mr. Shoup provided additional employment documents and endorsements but failed to provide complete and satisfactory records. Acting President Draugalis advised Mr. Shoup a list of employment, including place, supervisor, times/dates and responsibility(s) in chronological order with no gaps in time was what the Board was hoping to receive. The material provided by Mr. Shoup is found to be incomplete and he was advised that nothing less than a complete documentation would be accepted. Mr. Draugalis asked Mr. Shoup if he understood what the Board was seeking. Mr. Shoup indicated that he understood.

Mr. Lloyd called the Board's attention to the appropriation balance of $458,218 to complete the fiscal year.

Other issues included discussion of ACPE's proposal to evaluate the Pharmacy College Program at the American University of Beirut and the impact of the possible accreditation of this program on Arizona pharmacist licensure for their graduates. Mr. Lloyd entertained comments and questions from the Board prior to concluding his remarks.

B. Deputy Director

Mr. Wand called the Board's attention to the compliance officer activity report included in the meeting book; Hal indicated that compared to last year compliance visits were about 100 behind. He explained that last year we had a contract compliance person that performed 50 inspections which accounted for some of the difference.

Mr. Wand remarked that with the recent addition of Ms. Wilson as a full time compliance officer there should be no problem completing the require compliance visits by the end of the calendar year.

Mr. Wand also mentioned that Compliance Officer Dennis Waggoner will be attending the DEA investigator training academy in Virginia at little or no expense to the Board.

Mr. Wand reported on a compliance concern involving an individual that is allegedly pursuing employment as a pharmacist in Arizona using a forged pharmacist license. Presiding officer Draugalis indicated that this issue requires legal advice and would best be discussed in Executive Session with our Assistant Attorney General.

On motion by Ms. McCoy and Mr. Ketcherside, the Board unanimously agreed to recess the open meeting and reconvene in Executive Session for the purpose of obtaining legal advice.

Mr. Draugalis advised the audience that the meeting would reconvene at 1:15 p.m.

Mr. Draugalis reconvened the meeting at 1:20 p.m.

Deputy Director's Report continued: The issue of an individual using a forged Arizona Pharmacist License to practice without a license was revisited.

On motion by Mr. Mc Allister and Mr. Drake, the Board voted unanimously to direct Assistant Attorney General Victoria Martin to seek an injunction preventing this party from continuing to seek employment as a pharmacist while not having a license to practice in Arizona.

AGENDA ITEM V - PROPOSED RULES

Compliance Officer/Rules Writer Dean Wright advised the Board of the progress and current status of the Drug Therapy Management Rules (A.A.C R4-23-421 thru 429). Mr. Wright also provided a detailed outline of the existing and recently passed legislative changes to the rule making procedure. Wright indicated that the new legislation imposes a 60 day waiting period after a rule is approved by Governor's Regulatory Review Council(GRRC) before any new rule becomes effective. Mr. Wright estimates that the earliest the Drug therapy Management Rule could become effective is mid-November 2002. Dean reported that the time-frame for public comment had expired and there were no negative comments received, he then invited questions from the Board. At the conclusion of the discussion by the Board and

on motion by Mr. McAllister and Mr. Ketcherside, the Board voted unanimously to approve the rules as presented and to direct the staff to submit it to GRRC for final approval.

AGENDA ITEM VI - COMPLAINT REVIEW

The Consumer Complaint Review Committee met on June 19, 2002 to review eleven consumer complaints and make recommendations to the Board for resolution. Member Paul Draugalis directed the Boards attention to the committee's report with recommendations and continued by providing a synopsis of the committees findings. Mr. Draugalis invited the Board's comments and offered to provide additional insight as to the committee's recommendations. In the matter of two complaints(number(#)'s 2545 and 2556) Mr. Draugalis excused himself, member Ketcherside provided the background in these items.

On motion by Mr. McAllister and Mr. Drake the Board voted 4 in favor and 1 opposed to amend complaint # 2545 to include a $500 civil penalty per count and to extend probation on the licensee plus require medication dispensing error prevention continuing education course.

On motion by Mr. McAllister and Ms. McCoy, the Board unanimously agreed to accept the committee's recommendations on the balance of the complaints, see listing below:

• Complaint # 2541 - No Further Action
• Complaint # 2542 - Appear Before the Board
• Complaint # 2543 - Warning Letter to Manufacturer
• Complaint # 2545 - Consent Agreement/Hearing
• Complaint # 2546 - Appear Before the Board
• Complaint # 2547 - Appear Before the Board & Letter to Prescriber
• Complaint # 2548 - Warning Letter to Pharmacist
• Complaint # 2549 - Appear Before the Board
• Complaint # 2550 - No Further Action & Letter to Prescriber
• Complaint # 2553 - Appear Before the Board
• Complaint # 2556 - No Further Action

AGENDA ITEM VII - ARIZONA PHARMACY ASSOCIATION REPORT

APA Executive Director, Kathy Boyle reminded everyone the second Joint Meeting of the Arizona Pharmacy Association and the Arizona Society of Hospital Pharmacists was being held at the same facility where the Board was meeting and encouraged folks to attend, she also reminded everyone that the annual meeting will offer copious amounts of continuing education for various practice specialities.

Ms. Boyle commented on the legislative changes made in the 2002 session that are likely to impact the practice of pharmacy in Arizona.

AGENDA ITEM VIII - CONFERENCES

COMPLAINT # 2516

Acting President Draugalis invited the conferee and their supervisor to approach the Board.

Patrick Tacderan, R.Ph. and Melanie Malee, Supervisor appeared pursuant to a consumer complaint alleging a dispensing error. Compliance Officer Cheryl Frush provided an overview of her complaint investigation.

Mr. Draugalis asked Mr. Tacderan to describe the events leading to the consumer complaint. Mr. Tacderan told the Board that he is very concerned that an error occurred and that he has initiated an improved prescription verification procedure that he believes will dramatically reduce the likelihood of dispensing errors.

Mr. Draugalis asked the conferee if the prescriber was notified of the dispensing error. Mr. Tacderan said he was not aware if the prescriber was contacted, Mr. Draugalis stated it was always a good idea to do that. Before being excused, Mr. Draugalis reminded Mr. Tacderan that every prescription required the total attention of the pharmacist.

COMPLAINT # 2522

Christel Bird, R. Ph. and supervisor Paul Smith appeared pursuant to confusion relevant to transferring of prescription orders relating to juvenile detention patients that move from one facility to another. Compliance Officer Cheryl Frush provided the Board with an overview of her investigation.

Acting President Paul Draugalis called on Ms. Bird to tell the Board what happened to cause a complaint to be filed. Ms. Bird and Mr. Smith both provided a detailed summary of the events leading to this compliant. Ms. Bird concluded her remarks by stating that as a result of the incident, she and Mr. Smith have initiated a completely revised policy and procedure for the 'transfer of prescriptions' for juvenile detention patients, and that the new system is working well. Mr. Draugalis encouraged the conferees and all pharmacists to periodically review policies with the goal of making improvements.

COMPLAINT # 2531

Tammara Roberson, R. Ph. and Ralph Krolick, R. Ph. appeared with Melissa Christensen and Bruce Painter, pharmacy supervisor and corporate pharmacy director respectively.

Compliance Officer Dean Wright provided a review of his investigation of the consumer complaint.

Presiding Officer, Paul Draugalis invited Mr. Krolick to share his recollection of the events leading to this conference. Mr. Krolick began by stating that he has not worked for the corporate owner of the pharmacy involved for several months. Krolick made several negative observations and comments about the company and the pharmacy operation including that the pharmacy mentioned in the complaint was understaffed. A discussion relating to pharmacy staffing policies followed. Mr. Krolick implied that pharmacists in more than one pharmacy in the chain felt they were understaffed. The Board encouraged both the employee and the employer to assess staffing on an individual pharmacy basis in an attempt to better serve the public and minimize prescription dispensing incidents. Ms. Roberson described measures that have recently been taken to preclude a repeat of the incident triggering the compliant.

COMPLAINT # 2535

Due to a conflict of interest, Mr. Draugalis appointed Mr. Ritt to conduct this conference, Mr. Draugalis did not participate.

Pharmacist Nancy Padrez and supervisor Dean Burton appeared pursuant to a consumer complaint alleging a dispensing error.

Compliance Officer Dennis Waggoner provided a summary of his investigation in this matter.

Mr. Ritt inquired if there is or was anticipated litigation in this matter. Mr. Burton indicated, none that he was aware of. Mr. Ritt asked Ms. Padrez to summarize the events leading to the complaint and what has been done to improve the practice site/policies. She described the events and the dispensing procedures in place at the time.

Ms. Padrez also reported that several changes have been made in product shelf placement and warning stickers on sound-alike drugs. She is satisfied that the system is better now than it was previously

Mr. Ritt encouraged Ms. Padrez to continue to seek ways to improve the operation.

COMPLAINT # 2537

Acting President Draugalis invited pharmacist Charles Patterson and supervisor Joe Hands to approach the Board.

Compliance Officer Ed Hunter described the findings of his investigation.

Mr. Patterson was asked by Mr. Draugalis to summarize the events contributing to this complaint. Mr. Patterson stated that the incident took place about two years ago and at that time the drug interaction in question was not well documented nor widely publicized. Mr. Patterson did notice a computer screen duplication of therapy statement and did visit with the patient about the drug duplication and the prescribers intentions. There appeared to be no concerns as far as the consumer was aware. Several Board Members directed questions to Mr. Patterson on specific issues relating to the complaint. On conclusion of the comments and questions, Mr. Patterson was excused and encouraged to remain mindful of duplication of drug therapy situations.

AGENDA ITEM IX - CONSENT AGREEMENTS

Acting President Draugalis invited Deputy Director Wand to advise the Board of the status of the Consent Agreements listed in the agenda.

Mr. Wand indicated that Consent Agreement # 3 Notice of Hearing 2002-09-PHR issued to Walgreens Drug # 2079 would be continued until the August meeting at the request of the respondent.

Mr. Wand stated the remaining three consents, 2002-07-PHR, 2002-08-PHR and 2002-10-PHR have all been signed and returned to the Board office. Because the three consents(see above) have been approved by the respondent(s) and returned to the office; one motion to accept all three is in order. There was no discussion required, and on motion by Mr. McAllister and Ms. McCoy, the Board unanimously agreed to the Findings of Fact, the Conclusions of Law and the Order in the following notices:

• 1. Kevin Dennick
  2002-07-PHR
• 2. Osco Drug #2079
  2002-08-PHR
• 3. Kelly Seabloom
  2002-10-PHR

AGENDA ITEM X - HEARINGS

There were no hearings scheduled for this meeting, the agenda item was posted in the event that a consent agreement was not accepted and a hearing was necessary.

AGENDA ITEM XI - FIVE YEAR RULES REVIEW

Compliance Officer Rules writer Dean Wright provided a brief overview of the five year rules review process/progress. Mr. Wright also distributed to the Board a copy of the final document for approval prior to it being sent to GRRC. Dean further reminded the Board Members that this was a relatively small review because our package was divided in to two parts for this exercise. Next year's submission would be more extensive. Following Mr. Wrights presentation and

on motion by Mr Ritt and Mr. Ketcherside, the Board agreed unanimously to approve the report for submission.

AGENDA ITEM XII - NABP DISTRICT 8 SCHOLARSHIP PRESENTATION
See pre-meeting comments at beginning of minutes for this item.

AGENDA ITEM XIII - TECHNICIAN REGISTRATION

Executive Director Lloyd reported that progress is being made in the preparation of material to request legislative authority to register pharmacy technicians as a public health protection measure. Arizona Pharmacy Association has agreed to assist in this project. Efforts will continue through July and August with a progress report at the August meeting.

AGENDA ITEM XIV - REQUEST OF PAPA PARTICIPANT RECORDS

Pursuant to the statute(A.R.S. 32-1932(01)) referencing the impaired pharmacist program and the procedure for the Board to obtain participant records in the event of a participant's program participation deficiency....

on motion by Mr. McAllister and Ms. McCoy, the Board unanimously agreed to have the Executive Director request a copy of the complete file of participant Debbie Grabowski, from PAPA.

AGENDA ITEM XV - CALL TO THE PUBLIC

Acting President Draugalis invited audience members that wish to make suggestions or comments to the Board to approach the microphone and state their case, Mr. Draugalis reminded the audience that the Board is bound by statute to not respond to comments since the items are not part of the agenda.
Comments were offered on the following:

- The Board should establish safe staffing minimums for community pharmacies.

- A Pharmacist stated that a number of forged/fake prescriptions for controlled substances were being circulated in the Ahwatukee Foothills area.

AGENDA ITEM XVI - ADJOURNMENT
There being no further business to come before the Board and on motion by Mr. Ritt and Ms. McCoy, the Board unanimously agreed to adjourn at 2:40 p.m.